The results showed that CLDN6-CAR1 NK cells constructed by self-activation elements had stronger cell activation and killing ability, and these modifications to our CAR-NK cells will be tested in future works to further improve the efficacy against clinical ovarian cancer. The gene discussed is CLDN6; the disease is ovarian cancer.